ABSTRACT
V ertebroplasty using bone cement is well known to provide marked relief of prolonged pain from VCF and to improve ADL for patients. 1, 2 However, at present, a major placebo component to the analgesic effects exerted by vertebroplasty cannot be ruled out. 3, 4 There are many reports of randomized studies comparing conservative therapies and revealing the usefulness of vertebroplasty. 1, 2 Because the natural course of VCF remarkably impacts therapeutic effects, a simple comparison with patients receiving conservative therapy is insufficient to demonstrate whether intervertebral bone cement infusion actually contributes to pain relief. Kallmes et al 5 and Buchbinder et al 6 compared therapeutic effects between vertebroplasty and a sham subcutaneous puncture as a control procedure to demonstrate the efficacy of bone cement infusion, but efficacy could not be confirmed. However, the presence or absence of pseudoarthrosis was not considered in these studies. Vertebroplasty for VCF was originally a procedure expected to exert analgesic effects via injection of bone cement into vertebral bodies destabilized by pseudoarthrosis. 7, 8 In patients without pseudoarthrosis, no theoretic evidence exists for performing this procedure. We assessed the validity of intervertebral bone cement infusion for treating painful VCF based on the presence or absence of pseudoarthrosis. In patients with and without vertebral mobility before surgery, considered separately, the therapeutic effects of vertebroplasty were compared with those of the vertebral perforation procedure in which vertebral bodies were not injected with bone cement but rather were only perforated. In the second half of the study period, from September 2009 to April 2011, percutaneous vertebral perforation, in which vertebral bodies were not injected with bone cement but rather were only perforated, was performed in 67 patients (perforation group). We excluded those who insisted on bone cement infusion and did not undergo vertebral perforation. In all patients, simple dynamic lumbar radiography, lumbar CT, and lumbar MR imaging were performed before surgery to assess the presence or absence of vertebral mobility. We sufficiently explained treatment procedures and enrollment in this study to the patients and obtained their informed consent.
MATERIALS AND METHODS

Subjects
Inclusion and Exclusion Criteria
The inclusion criteria were 1) VCF with 0%-90% loss of vertebral body height on x-ray of the spine; 2) severe back pain related to a single VCF refractory to analgesic medication for at least 2 weeks; 3) pain with a VAS score of 5 or higher interfering with ADL, tapping pain at the spinal process of the fractured vertebral body; and 4) the high signal intensity on STIR imaging and low signal intensity on T1WI in the affected vertebral body. The exclusion criteria were 1) uncorrected coagulopathy, 2) local or systemic infection, 3) secondary osteoporosis, 4) inability to give informed consent, 5) impaired cardiopulmonary function, 6) dementia, 7) painless VCF, 8) spinal metastatic cancer, and 9) neurologic symptoms.
Surgical Procedures
Percutaneous Vertebral Body Perforation (Perforation Group). We previously reported the surgical procedure of percutaneous vertebral body perforation. 9 All patients were operated on by 1 of the authors (M.K.), who previously performed 610 vertebroplasties. Surgery was performed with the patient in the prone position under local anesthesia. Under C-arm guidance, 13-ga biopsy needles were inserted via bilateral transpedicular routes into the anterior third of the vertebral body. Blood or effusion in the vertebral body was aspirated. Next, contrast medium was injected through the bilateral needles, and the position of the tip of each needle, its communication with the vertebral vein, and the efflux pattern of the contrast medium were then checked. Finally, irrigation with 50 mL of saline was performed via each needle. Surgery was completed by withdrawing both needles.
Percutaneous Vertebroplasty (PVP Group). All patients were operated on by 1 of the authors (M.K.). Surgery was performed with the patient in the prone position under local anesthesia. Under C-arm guidance, a 13-ga biopsy needle was inserted via a unilateral transpedicular route into the anterior third of the vertebral body. Contrast medium was injected through the needle, and the position of the tip of the needle and the efflux pattern of the contrast medium were then checked. A polymethylmethacrylate mixture was injected into the vertebral body. Surgery was completed by withdrawing the needle. During cement injection, fluoroscopic monitoring with a C-arm unit was used in both planes.
Outcome Evaluation
Pain was evaluated before and at 2 days (next day), 1 week, and 3 months after surgery using a VAS on a numeric rating system (10 ϭ maximum pain to 0 ϭ no pain). ADL were evaluated before the surgery, 2 days (next day) after surgery, and 3 months after surgery using the following 5-point scale: grade 0 ϭ complete independence; grade 1 ϭ light assistance and being able to walk with a stick; grade 2 ϭ moderate assistance and needing a wheelchair for locomotion; grade 3 ϭ major assistance and mostly staying in bed; and grade 4 ϭ a bed-ridden state and needing total assistance. First, we compared postoperative changes in VAS and ADL scores between patients with and without vertebral mobility in each treatment group, respectively. Next, we compared scores between the PVP and perforation groups based on the presence of vertebral mobility. The presence or absence of mobility of the affected vertebral bodies before surgery was assessed with dy- 
Statistical Analysis
Statistical analyses were performed using Stat View 5.0 software (SAS Institute, Cary, North Carolina). For comparison of demographic characteristics, VAS scores on follow-up, and complications between the 2 groups, we applied the Mann-Whitney U test or the Fisher exact test. All data are presented as mean Ϯ standard deviation, and differences were considered statistically significant at a P value Ͻ.05.
RESULTS
The demographic data of the PVP and perforation groups are presented in Table 1 . There were no significant differences in age, sex ratio, localization of treated vertebral bodies, preoperative VAS scores, or symptom duration (P Ͼ .05). Preoperative dynamic radiography revealed mobility of vertebral bodies in 23 PVP group (34.3%) and 32 perforation group (50%) patients. In the PVP group, VAS scores were markedly decreased immediately after surgery in both groups of patients (those with and those without vertebral mobility), and no significant difference was observed for 3 months (P Ͼ .05, Table 2 ). On the other hand, in the perforation group, postoperative improvement of VAS scores was poorer in patients with, than in those without, vertebral mobility, and a significant difference was observed from postoperative day 7 and onward (day 7 to day 90, P Ͻ .05, Table 2).
In patients with preoperative vertebral mobility, VAS scores were significantly improved immediately after surgery-and this was sustained for 3 months-in the PVP group compared with the perforation group (P Ͻ .05; Fig 2, Table 3 ). However, in patients without vertebral mobility, no significant difference was observed in postoperative improvement of VAS scores between the PVP and perforation groups (P Ͼ .05; Fig 2, Table 3 ). Concerning changes in ADL scores, there was no statistically significant difference between the 2 treatment groups for the first 3 months after surgery, regardless of the presence or absence of vertebral mobility. However, in patients with vertebral mobility, ADL scores were better in the PVP than in the perforation group.
During the 12-month postoperative follow-up period, new fractures occurred in 28.4% of patients in the PVP group. This frequency was significantly higher than the 9.8% in the perforation group (P Ͻ .01). In cases with vertebral mobility especially, though a new fracture occurred in 1 of 32 (3.1%) perforation group patients, new fractures occurred in 9 of 23 (39.1%) PVP group patients (Table 4) .
DISCUSSION
We performed vertebral perforation, in which vertebral bodies were not injected with bone cement but were only perforated, as the control procedure against vertebroplasty for painful VCF. The former procedure is a modification of bone marrow decompression performed for painful fractures. Bone marrow decompression was previously performed for pain due to long bone fractures and so on, based on the theory that the onset of fracture pain is closely associated with bone marrow edema. [10] [11] [12] [13] [14] [15] [16] [17] [18] Past reports suggest that bone marrow decompression may reduce intramedullary pressure in vertebral bodies and cause changes in blood circulation. [10] [11] [12] [13] [14] [15] [16] [17] [18] Some clinicians regard these procedures as treatment. In fact, anticipating analgesic effects, we have also performed these procedures for patients with painful VCF. However, because vertebral bodies are also perforated before bone cement infusion, even in vertebroplasty, the difference between vertebroplasty and vertebral perforation is based on whether or not bone cement was infused. Thus, we speculated that the significance of intervertebral bone cement infusion could be demonstrated by comparing analgesic effects between these treatment procedures.
According to the results of this study, analgesic effects were significantly higher in patients with vertebral mobility in the PVP group than in those in the perforation group, and postoperative improvement of ADL scores was observed in the former group. It has been noted that stabilization of destabilized vertebral bodies is necessary for pain relief in patients with pseudoarthrosis. 7, 8 Our results confirmed that bone cement infusion truly plays an important role in analgesic effects on fractured vertebral bodies with vertebral mobility. Meanwhile, marked analgesic effects were also observed in patients without vertebral mobility in the PVP group. Because the pain mechanism has not been elucidated in patients with VCF without vertebral mobility, the mechanism by which bone cement infusion exerts analgesic effects remains unknown. More importantly, the analgesic effects obtained in the patients with VCF without vertebral mobility in the perforation group without bone cement infusion were approximately the same as the effects obtained in the PVP group. Because pain may be spontaneously relieved in patients without vertebral mobility, it also cannot be ruled out that the analgesic effects observed in both treatment groups might have been a placebo. This result does not affirm that bone cement infusion is necessary for patients with fractures without vertebral mobility. This is also reflected by the fact that no difference was observed in changes in ADL scores between the 2 treatment groups. Because pathologic conditions and pain mechanisms differ between VCF with and without vertebral mobility, 19 treatment procedures need to be selected according to pathologic conditions. Many past randomized studies involved patients with bone marrow edema detected by preoperative MR imaging, and both pathologic conditions are included. 1, 5, 6 Thus, if only patients with pseudoarthrosis had been included in the assessment, we consider the difference in therapeutic effects to possibly have been more apparent between the vertebroplasty and control groups. We previously reported on the analgesic effects of vertebral perforation on painful VCF. 9 In this study, the results of multivariate analysis revealed that the analgesic effects were low in patients with severe collapse of vertebral bodies before surgery. As a possible explanation for this, we noted that VCF patients with severe collapse had a longer time since onset and higher frequency of vertebral mobility than those with mild collapse. However, the presence or absence of vertebral mobility was not assessed. 9 We demonstrated that intervertebral bone cement infusion apparently contributes to pain relief in patients with painful VCF with vertebral mobility. However, the incidence of new fractures after surgery is extremely high. This should be adequately understood by patients before surgery. On the other hand, it is not certain whether intervertebral bone cement infusion per se contributes to pain relief in patients with fractures lacking vertebral mobility. Given the risk of complications associated with bone cement infusion, we advocate caution in the application of vertebroplasty.
Limitations
In the present study, we used vertebral perforation as a control procedure against PVP to assess the validity of bone cement infusion. As noted above, there is no conclusive evidence that treatment with only puncture of vertebral bodies per se has no analgesic effect on compression fracture. Thus, it is not certain whether this treatment is appropriate as a control procedure. However, if a difference in therapeutic effects is observed between the 2 treatment groups, we consider this to demonstrate the therapeutic significance of intervertebral bone cement infusion.
Second, the patients were not randomized, and vertebral perforation was not performed under blinded conditions because those undergoing the procedure were preoperatively informed that bone cement would not be injected. However, the patients enrolled in this study were assigned to treatment procedures according to study period. PVP was performed in those enrolled during the first half of the study period and vertebral perforation in those enrolled during the second half. Thus, at least the treatment selection was not biased. Moreover, because all patients in this study underwent surgery with an expectation of analgesic effects from it, we consider a large difference in placebo effects between the treatment groups to be unlikely. Note:-Preop indicates preoperative. ADL were evaluated using the following 5-point scale outlined in the text. 
